The Covid 19 vaccine candidate Moderna on Friday has announced that the United States government will receive an additional 100 million doses of Moderna Inc’s COVID-19 vaccine, as the country prepares for a vaccine roll-out that officials hope will help get the surging pandemic under control. Till date US has ordered a total of 200 million doses, the company said.
Of the order received, the first set of 20 million doses will be delivered by the end of December and the rest will come in the first quarter of 2021, added the vaccine candidate. The United states has entered into an agreement with Moderna to procure 100 million doses of its potential COVID-19 vaccine for about $1.5bn, the agreement has an option to secure an additional 400 million doses. The country which recorded more than 15.7 million COVID-19 cases so far standing at Number no 1 got a bit relaxation as FDA approves EUA Emergency Use Approval for Pfizer.
Moderna which is in fray has requested the panel of outside advisers to the US Food and Drug Administration (FDA) to schedule a meeting on December 17 to discuss Moderna’s request for an emergency use authorisation for its vaccine. Clinical studies have shown Moderna’s vaccine to be about 94 percent effective. Moderna’s vaccine will require two injections, at a gap of 28 days. Moderna’s vaccine remains stable for six months at negative 20 degrees Celcius (negative four degrees Fahrenheit) and for 30 days in a standard medical refrigerator, the statement from the company reads.